KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BeOne Medicines (ONC) Return on Invested Capital (2016 - 2025)

BeOne Medicines (ONC) has disclosed Return on Invested Capital for 10 consecutive years, with 0.02% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Invested Capital rose 26.0% to 0.02% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.02%, a 26.0% increase, with the full-year FY2024 number at 0.2%, up 12.0% from a year prior.
  • Return on Invested Capital was 0.02% for Q3 2025 at BeOne Medicines, up from 0.06% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q3 2025 to a low of 0.39% in Q3 2021.
  • A 5-year average of 0.26% and a median of 0.28% in 2021 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: surged 32bps in 2021, then dropped -19bps in 2023.
  • BeOne Medicines' Return on Invested Capital stood at 0.39% in 2021, then grew by 5bps to 0.37% in 2022, then rose by 9bps to 0.34% in 2023, then surged by 47bps to 0.18% in 2024, then skyrocketed by 109bps to 0.02% in 2025.
  • Per Business Quant, the three most recent readings for ONC's Return on Invested Capital are 0.02% (Q3 2025), 0.06% (Q2 2025), and 0.11% (Q1 2025).